Healthcare provider profile · identity verified

Brigitte Renee Cormier, DO

Family Practice · KAHOKA, MO · NPI 1124138367

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	190	43
Levothyroxine Sodium	Levothyroxine Sodium	183	40
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	169	22
Lisinopril	Lisinopril	158	38
Alprazolam	Alprazolam	142	17
Pantoprazole Sodium	Pantoprazole Sodium	131	27
Tramadol Hcl	Tramadol Hcl	123	18
Gabapentin	Gabapentin	116	23
Furosemide	Furosemide	108	28
Hydrochlorothiazide	Hydrochlorothiazide	107	19
Omeprazole	Omeprazole	107	27
Metformin Hcl	Metformin Hcl	105	19
Duloxetine Hcl	Duloxetine Hcl	91	18
Potassium Chloride	Potassium Chloride	82	18
Amlodipine Besylate	Amlodipine Besylate	79	15
Albuterol Sulfate Hfa	Albuterol Sulfate	73	19
Rosuvastatin Calcium	Rosuvastatin Calcium	73	16
Metoprolol Succinate	Metoprolol Succinate	69	15
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	67	suppressed
Losartan Potassium	Losartan Potassium	58	15
Metformin Hcl Er	Metformin Hcl	58	11
Clonidine Hcl	Clonidine Hcl	57	suppressed
Alendronate Sodium	Alendronate Sodium	56	suppressed
Pregabalin	Pregabalin	56	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	55	13
Meloxicam	Meloxicam	54	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	48	12
Celecoxib	Celecoxib	47	14
Clopidogrel	Clopidogrel Bisulfate	46	suppressed
Pravastatin Sodium	Pravastatin Sodium	46	13
Trazodone Hcl	Trazodone Hcl	46	suppressed
Citalopram Hbr	Citalopram Hydrobromide	45	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	44	11
Sertraline Hcl	Sertraline Hcl	43	suppressed
Glipizide	Glipizide	42	suppressed
Cephalexin	Cephalexin	41	26
Temazepam	Temazepam	41	suppressed
Prednisone	Prednisone	40	21
Famotidine	Famotidine	37	suppressed
Eliquis	Apixaban	36	suppressed
Glipizide Er	Glipizide	36	suppressed
Spironolactone	Spironolactone	36	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	36	suppressed
Baclofen	Baclofen	35	suppressed
Aripiprazole	Aripiprazole	34	suppressed
Jardiance	Empagliflozin	33	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	32	32
Escitalopram Oxalate	Escitalopram Oxalate	32	suppressed
Ozempic	Semaglutide	32	suppressed
Carvedilol	Carvedilol	31	suppressed
Clonazepam	Clonazepam	31	suppressed
Ropinirole Hcl	Ropinirole Hcl	31	suppressed
Tizanidine Hcl	Tizanidine Hcl	31	12
Simvastatin	Simvastatin	29	suppressed
Diazepam	Diazepam	28	suppressed
Diclofenac Sodium	Diclofenac Sodium	28	suppressed
Chlorthalidone	Chlorthalidone	27	suppressed
Nebivolol Hcl	Nebivolol Hcl	27	suppressed
Oxycodone Hcl	Oxycodone Hcl	26	suppressed
Paroxetine Hcl	Paroxetine Hcl	26	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	26	suppressed
Synthroid	Levothyroxine Sodium	25	suppressed
Estradiol	Estradiol	24	suppressed
Lorazepam	Lorazepam	24	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	24	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	23	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	23	suppressed
Januvia	Sitagliptin Phosphate	23	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	23	suppressed
Testosterone Cypionate	Testosterone Cypionate	23	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	22	suppressed
Terbinafine Hcl	Terbinafine Hcl	22	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	21	suppressed
Nabumetone	Nabumetone	21	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	20	14
Amoxicillin	Amoxicillin	19	13
Farxiga	Dapagliflozin Propanediol	19	suppressed
Oxcarbazepine	Oxcarbazepine	19	suppressed
Allopurinol	Allopurinol	18	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	18	15
Buspirone Hcl	Buspirone Hcl	18	suppressed
Ibuprofen	Ibuprofen	18	suppressed
Levetiracetam	Levetiracetam	18	suppressed
Neomycin-Polymyxin-Dexameth	Neomycin/Polymyxin B/Dexametha	18	11
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	18	suppressed
Valsartan	Valsartan	18	suppressed
Xarelto	Rivaroxaban	18	suppressed
Montelukast Sodium	Montelukast Sodium	17	suppressed
Ondansetron Odt	Ondansetron	17	suppressed
Benazepril Hcl	Benazepril Hcl	16	suppressed
Donepezil Hcl	Donepezil Hcl	16	suppressed
Fluticasone Propionate	Fluticasone Propionate	16	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	16	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	16	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Telmisartan	Telmisartan	16	suppressed
Finasteride	Finasteride	15	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	15	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	15	suppressed
Methadone Hcl	Methadone Hcl	15	suppressed
Sucralfate	Sucralfate	15	suppressed
Azithromycin	Azithromycin	14	13
Levofloxacin	Levofloxacin	14	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	14	suppressed
Atenolol	Atenolol	13	suppressed
Gemfibrozil	Gemfibrozil	13	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	13	suppressed
Vyvanse	Lisdexamfetamine Dimesylate	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	suppressed
Fentanyl	Fentanyl	12	suppressed
Ibandronate Sodium	Ibandronate Sodium	12	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Olanzapine	Olanzapine	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Dexmethylphenidate Hcl	Dexmethylphenidate Hcl	11	suppressed
Fenofibrate	Fenofibrate,micronized	11	suppressed
Hydralazine Hcl	Hydralazine Hcl	11	suppressed
Klor-Con M20	Potassium Chloride	11	suppressed
Nucynta	Tapentadol Hcl	11	suppressed
Risperidone	Risperidone	11	suppressed
Rybelsus	Semaglutide	11	suppressed
Warfarin Sodium	Warfarin Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error